Allergen immunotherapy: efficacy, persistence, consistency, and cost effectiveness
Allergen immunotherapy-mechanism of action. Allergen immunotherapy adherence: persistence and consistency. Economic impactof medication non-adherence. Research studies on improving ait adherence: key findings. Literature review of persistence of ait.
| Рубрика | Медицина |
| Вид | статья |
| Язык | английский |
| Дата добавления | 26.04.2021 |
| Размер файла | 37,7 K |
Отправить свою хорошую работу в базу знаний просто. Используйте форму, расположенную ниже
Студенты, аспиранты, молодые ученые, использующие базу знаний в своей учебе и работе, будут вам очень благодарны.
58. Lamkin M, Elliott C. Curing the disobedient patient: medication adherence programs as pharmaceutical marketing tools. J Law Med Ethics. 2014;42[4]:492--500.
59. Senna G, Lombardi C, Canonica GW, Passalacqua G. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. J Allergy ClinImmunol. 2010;126[3]:668--9.
60. Rhodes BJ. Patient dropouts before completion of optimal dose, multiple allergen immunotherapy. Ann Allergy Asthma Immunol. 1999;82[3]:281--6.
61. KiotseridisH, Arvidsson P, Backer V, Braendholt V, Tunsater A. Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax- a real life study. NPJprimary care respiratory medicine. 2018;28[1]:4.
62. Hankin CS, Cox L, Lang D, Levin A, Gross G, Eavy G, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy ClinImmunol. 2008;121[1]: 227--32.
63. Savi E, Peveri S, Senna G, Passalacqua G. Causes of SLIT discontinuation and strategies to improve the adherence: a pragmatic approach. Allergy. 2013;68[9]: 1193--5.
64. Vita D, Caminiti L, Ruggeri P, Pajno GB. Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy. 2010;65[5]:668--9.
65. Epstein TE, Tankersley MS. Are Allergen Immunotherapy Dose Adjustments Needed for Local Reactions, Peaks of Season, or Gaps in Treatment? J Allergy ClinImmunolPract. 2017;5[5]:1227--33.
66. Wong PH, Quinn JM, Gomez RA, Webb CN. Systemic reactions to immunotherapy during mountain cedar season: implications for seasonal dose adjustment. J Allergy ClinImmunolPract. 2017;5[5]:1438--9 e1.
67. Brehler R, Klimek L, Pfaar O, Hauswald B, Worm M, Bieber T. Safety of a rush immunotherapy build-up schedule with depigmented polymerized allergen extracts. Allergy Asthma Proc. 2010;31[3]:e31--8.
68. Cardona R, Lopez E, Beltran J, Sanchez J. Safety of immunotherapy in patients with rhinitis, asthma or atopic dermatitis using an ultra-rush buildup. A retrospective study. AllergolImmunopathol[Madr]. 2014;42[2]:90--5.
69. Casanovas M, Martin R, Jimenez C, Caballero R, Fer- nandez-Caldas E. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol. 2006;139[2]:153--8.
70. Pfaar O, Mosges R, Hormann K, Klimek L. Safety aspects of Cluster immunotherapy with semi-depot allergen extracts in seasonal allergic rhinoconjunctivitis. Eur Arch Otorhinolaryngol. 2010;267[2]:245--50.
71. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol. 2002;88[4]:391--4.
72. Carlson GS, Wong PH, White KM, Quinn JM. Evaluation of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker therapy in immunotherapy-associated systemic reactions. J Allergy ClinImmunolPract. 2017;5[5]:1430--2.
73. Cox L, Nelson H, Lockey R, Calabria C, Chacko T, Finegold I, et al. Allergen immunotherapy: a practice parameter third update. J Allergy ClinImmunol. 2011; 127[1 Suppl]:S1--55.
74. Lim CE, Sison CP, Ponda P. Comparison of Pediatric and Adult Systemic Reactions to Subcutaneous Immunotherapy. J Allergy ClinImmunolPract. 2017;5[5]: 1241--7 e2.
75. Comberiati P, Marseglia GL, Barberi S, Passalacqua G, Peroni DG. Allergen-Specific Immunotherapy for Respiratory Allergy in Children: Unmet Needs and Future Goals. J Allergy ClinImmunolPract. 2017;5[4]:946--50.
76. Jonasson G, Carlsen KH, Mowinckel P. Asthma drug adherence in a long term clinical trial. Arch Dis Child. 2000;83[4]:330--3.
77. Bousquet J, Hellings PW, Agache I, Bedbrook A, Bachert C, Bergmann KC, et al. ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle. ClinTransl Allergy. 2016;6:47.
78. May JR, Dolen WK. Management of Allergic Rhinitis: A Review for the Community Pharmacist. ClinTher. 2017;39[12]:2410--9.
79. Jansen A, Andersen KF, Bruning H. Evaluation of a compliance device in a subgroup of adult patients receiving specific immunotherapy with grass allergen tablets [GRAZAX] in a randomized, open-label, controlled study: an a priori subgroup analysis. ClinTher. 2009; 31[2]:321--7.
80. Rand CS, Wise RA. Measuring adherence to asthma medication regimens. Am J RespirCrit Care Med. 1994; 149[2 Pt 2]:S69--76; discussion S7--8.
81. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42[3]:200--9.
82. Bender BG. Can health care organizations improve health behavior and treatment adherence? Popul Health Manag. 2014;17[2]:71--8.
83. ACAAI. New toolkit helps patients understand immunotherapy choices 2017 [cited 2018 Aug 19]. Available from: https://college.acaai.org/publications/college-insider/ new-toolkit-helps-patients-understand-immunotherapy- choices.
84. Borrelli B, Riekert KA, Weinstein A, Rathier L. Brief motivational interviewing as a clinical strategy to promote asthma medication adherence. J Allergy ClinImmunol. 2007;120[5]:1023--30.
85. Lockey RF, Hankin CS. Health economics of allergen- specific immunotherapy in the United States. J Allergy ClinImmunol. 2011;127[1]:39--43.
86. Hankin CS, Cox L, Bronstone A. The health economics of allergen immunotherapy. Immunology and allergy clinics of North America. 2011;31[2]:325--41, x.
87. Hankin CS, Cox L. Allergy immunotherapy: what is the evidence for cost saving? CurrOpin Allergy ClinImmunol. 2014;14[4]:363--70.
88. Canonica GW, Passalacqua G. Disease-modifying effect and economic implications of sublingual immunotherapy. J Allergy ClinImmunol. 2011;127[1]:44--5.
89. Hankin CS, Cox L, Lang D, Bronstone A, Fass P, Leather- man B, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large- scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol. 2010;104[1]:79--85.
90. Hankin CS, Cox L, Bronstone A, Wang Z. Allergy immunotherapy: reduced health care costs in adults and children with allergic rhinitis. J Allergy ClinImmunol. 2013;131[4]:1084--91.
91. Allen-Ramey F, Mao J, Blauer-Peterson C, Rock M, Nathan R, Halpern R. Healthcare costs for allergic rhinitis patients on allergy immunotherapy: a retrospective observational study. Curr Med Res Opin. 2017;33[11]: 2039--47.
92. Ariano R, Berto P, Tracci D, Incorvaia C, Frati F. Phar- macoeconomics of allergen immunotherapy compared with symptomatic drug treatment in patients with allergic rhinitis and asthma. Allergy Asthma Proc. 2006;27[2]: 159--63.
93. Petersen KD, Gyrd-Hansen D, Dahl R. Health-economic analyses of subcutaneous specific immunotherapy for grass pollen and mite allergy. AllergolImmunopathol [Madr]. 2005;33[6]:296--302.
94. Pokladnikova J, Krcmova I, Vlcek J. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy. Ann Allergy Asthma Immunol. 2008;100[5]:482--9.
95. Bachert C, Vestenbaek U, Christensen J, Griffiths UK, Poulsen PB. Cost-effectiveness of grass allergen tablet [GRAZAX] for the prevention of seasonal grass pollen induced rhinoconjunctivitis -- a Northern European perspective. ClinExp Allergy. 2007;37[5]:772--9.
96. Schadlich PK, Brecht JG. Economic evaluation of specific immunotherapy versus symptomatic treatment of allergic rhinitis in Germany. Pharmacoeconomics. 2000;17[1]: 37--52.
Размещено на Allbest.ru
Подобные документы
Coma - a life-threatening condition characterized by loss of consciousness, the lack of response to stimuli. Its classification, mechanism of development and symptoms. Types of supratentorial and subtentorial brain displacement. Diagnosis of the disease.
презентация [1,4 M], добавлен 24.03.2015Physical meaning of electron paramagnetic resonance and nuclear magnetic resonance. Splitting of energy levels. Zeeman effect. Spin probe. Device and mechanism of spectrometer and introscopy. The usage of EPR specters, NMR in medico-biological researches.
контрольная работа [153,5 K], добавлен 15.12.2015Хроническая обструктивная болезнь легких, распространенность, классификация. Симптомы, скорость прогрессирования заболевания. Оценка одышки по шкале Medical Research. Отношение к болезни у "бессимптомных" курильщиков. Диагностика и лечение обострений.
презентация [6,8 M], добавлен 10.12.2016A brief sketch of the life and professional development of Botkin as the Russian scientist, a gifted doctor. Botkin's value in world medicine, assessment of its scientific achievements. Analysis and themes of famous doctor, the direction of its research.
презентация [1,7 M], добавлен 10.12.2014The definition of alcohol abuse, its symptoms, signs and association with violence. The characteristic of binge drinking. Economic, biologic and social factors of alcohol dependence, the prevention measures of it in The United States and Europe.
презентация [3,2 M], добавлен 23.11.2014The history of plague. The disease. Mortality. Physicians. The physicians of the fourteenth century and the Black Death. Effects of The Black Death: religion, other effects. The Black Death in European architecture as in literature.
реферат [23,1 K], добавлен 23.01.2008Safety and attitudes toward law enforcement in persistence. Basic approaches to ensure the safety of law enforcement personnel in the development of independent Ukraine. Ways and methods of improvement of system of training of policemen in Ukraine.
реферат [33,0 K], добавлен 02.10.2012The collection and analysis of information with a view of improving the business marketing activities. Qualitative & Quantitative Research. Interviews, Desk Research, Test Trial. Search Engines. Group interviews and focus groups, Secondary research.
реферат [12,5 K], добавлен 17.02.2013Technical and economic characteristics of medical institutions. Development of an automation project. Justification of the methods of calculating cost-effectiveness. General information about health and organization safety. Providing electrical safety.
дипломная работа [3,7 M], добавлен 14.05.2014The main principles of marketing. The globalization of activity and costs decreasing. The personification of interaction and transition to e-marketing and the problem of e-marketing economic effectiveness. Marketing communications in the internet.
контрольная работа [29,3 K], добавлен 17.02.2011
